WE SPEAK DUCHENNE

Serial Number 98236329
Registration 7521106
700

Registration Progress

Application Filed
Oct 23, 2023
Under Examination
Approved for Publication
Jul 16, 2024
Published for Opposition
Jul 16, 2024
Registered
Oct 1, 2024

Trademark Image

WE SPEAK DUCHENNE

Basic Information

Serial Number
98236329
Registration Number
7521106
Filing Date
October 23, 2023
Registration Date
October 1, 2024
Published for Opposition
July 16, 2024
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Oct 1, 2024
Registration
Registered
Classes
035

Rights Holder

NS Pharma, Inc.

03
Address
140 East Ridgewood Avenue, Suite 280S
Paramus, NJ 07652

Ownership History

NS Pharma, Inc.

Original Applicant
03
Paramus, NJ

NS Pharma, Inc.

Owner at Publication
03
Paramus, NJ

NS Pharma, Inc.

Original Registrant
03
Paramus, NJ

Legal Representation

Attorney
Anthony F. Lo Cicero

Application History

12 events
Date Code Type Description Documents
Oct 1, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Oct 1, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jul 16, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 16, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 16, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 16, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 26, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 13, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 6, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 28, 2023 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Oct 27, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 26, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 035
Promoting public awareness of Duchenne muscular dystrophy; promoting the exchange of information and resources among individuals impacted by Duchenne muscular dystrophy to educate the public and impacted communities about the disease; promoting collaboration among patients, caregivers, parents, and clinicians to educate the public and communities impacted by Duchenne muscular dystrophy about the disease
First Use Anywhere: Jun 29, 2023
First Use in Commerce: Jun 29, 2023

Additional Information

Design Mark
The mark consists of the words WE SPEAK DUCHENNE contained within a speech bubble, with two groups of diagonal lines inside the bubble.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
035

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"DUCHENNE"